|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 30360 |
FusionGeneSummary for RANGAP1_FNTA |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RANGAP1_FNTA | Fusion gene ID: 30360 | Hgene | Tgene | Gene symbol | RANGAP1 | FNTA | Gene ID | 5905 | 2339 |
| Gene name | Ran GTPase activating protein 1 | farnesyltransferase, CAAX box, alpha | |
| Synonyms | Fug1|RANGAP|SD | FPTA|PGGT1A|PTAR2 | |
| Cytomap | 22q13.2 | 8p11.21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ran GTPase-activating protein 1segregation distorter homologsegregation distortion | protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaFTase-alphaGGTase-I-alphafarnesyl-protein transferase alpha-subunitprotein prenyltransferase alpha subunit repeat containing 2ras proteins prenyltransferase subunit alphatype | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | P46060 | P49354 | |
| Ensembl transtripts involved in fusion gene | ENST00000405486, ENST00000356244, ENST00000455915, ENST00000407260, | ENST00000302279, ENST00000342116, ENST00000524546, ENST00000529687, | |
| Fusion gene scores | * DoF score | 12 X 10 X 6=720 | 4 X 7 X 4=112 |
| # samples | 12 | 8 | |
| ** MAII score | log2(12/720*10)=-2.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/112*10)=-0.485426827170242 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: RANGAP1 [Title/Abstract] AND FNTA [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | RANGAP1 | GO:0046826 | negative regulation of protein export from nucleus | 16449645 |
| Hgene | RANGAP1 | GO:0090630 | activation of GTPase activity | 16428860 |
| Tgene | FNTA | GO:0018343 | protein farnesylation | 16893176|19228685 |
| Tgene | FNTA | GO:0018344 | protein geranylgeranylation | 16893176 |
| Tgene | FNTA | GO:0090044 | positive regulation of tubulin deacetylation | 19228685 |
| Tgene | FNTA | GO:0090045 | positive regulation of deacetylase activity | 19228685 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LUSC | TCGA-34-5239-01A | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000405486 | ENST00000302279 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-intron | ENST00000405486 | ENST00000342116 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3UTR | ENST00000405486 | ENST00000524546 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-5UTR | ENST00000405486 | ENST00000529687 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3CDS | ENST00000356244 | ENST00000302279 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-intron | ENST00000356244 | ENST00000342116 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3UTR | ENST00000356244 | ENST00000524546 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-5UTR | ENST00000356244 | ENST00000529687 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3CDS | ENST00000455915 | ENST00000302279 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-intron | ENST00000455915 | ENST00000342116 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3UTR | ENST00000455915 | ENST00000524546 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-5UTR | ENST00000455915 | ENST00000529687 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3CDS | ENST00000407260 | ENST00000302279 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-intron | ENST00000407260 | ENST00000342116 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-3UTR | ENST00000407260 | ENST00000524546 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
| intron-5UTR | ENST00000407260 | ENST00000529687 | RANGAP1 | chr22 | 41681367 | - | FNTA | chr8 | 42914235 | + |
Top |
FusionProtFeatures for RANGAP1_FNTA |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| RANGAP1 | FNTA |
| GTPase activator for RAN (PubMed:8146159,PubMed:8896452, PubMed:16428860). Converts cytoplasmic GTP-boundRAN to GDP-bound RAN, which is essential for RAN-mediated nuclearimport and export (PubMed:8896452, PubMed:27160050). Mediatesdissociation of cargo from nuclear export complexes containingXPO1, RAN and RANBP2 after nuclear export (PubMed:27160050).{ECO:0000269|PubMed:16428860, ECO:0000269|PubMed:27160050,ECO:0000269|PubMed:8146159, ECO:0000269|PubMed:8896452}. | Essential subunit of both the farnesyltransferase andthe geranylgeranyltransferase complex. Contributes to the transferof a farnesyl or geranylgeranyl moiety from farnesyl orgeranylgeranyl diphosphate to a cysteine at the fourth positionfrom the C-terminus of several proteins having the C-terminalsequence Cys-aliphatic-aliphatic-X. May positively regulateneuromuscular junction development downstream of MUSK via itsfunction in RAC1 prenylation and activation.{ECO:0000269|PubMed:12036349, ECO:0000269|PubMed:12825937,ECO:0000269|PubMed:16893176, ECO:0000269|PubMed:19246009,ECO:0000269|PubMed:8419339, ECO:0000269|PubMed:8494894}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RANGAP1_FNTA |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RANGAP1_FNTA |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| RANGAP1 | UBE2I, SUMO1, RAN, RANGAP1, BABAM1, MEPCE, PMS1, TOPORS, RANBP2, ARRB2, SIRT7, USPL1, CSNK2A1, PCGF2, NXF1, PRDX6, NDUFA7, SORD, PRPF8, DYNC1LI1, EFTUD2, HUWE1, PPIF, PNPT1, NCOA6, PPIB, MMS19, SOX2, LMNA, EGFR, GNAI3, GNAI1, CCL5, SENP1, NLK, MIB1, KIAA1279, ACTR2, ACTR3, ARPC1B, ARPC2, BAG1, CALU, DBNL, EEF2K, EFTUD1, IPO11, LPP, NIF3L1, NSUN2, OSGEP, PANK4, PPP2R5D, RPRD1B, SAE1, SH3GLB1, THG1L, TP53RK, TPD52L2, TPRKB, UFM1, SENP2, CUL7, OBSL1, RNF2, UBE2E3, RCC1, C11orf58, COL4A3BP, CPSF4, EEF1G, GNL1, GTF3C3, IPO5, KDM2A, NCL, PCF11, POLR3C, RALY, CPSF1, PTBP1, U2AF2, UBR5, XPO1, RGPD2, RGPD5, RGPD6, SUB1, SUPT5H, UBR4, NTRK1, SCARNA22, NUP85, NUP107, NUP35, KPNB1, NUP153, ATP6AP2, SEH1L, MYO18A, JUN, RBPJ, FOXB1, FOXE1, FOXJ3, TMUB1, FOXL1, FOXQ1, SNW1, CDC5L, CDH1, CTDSPL2, B2M, TMEM194A, DLD, DLST, PDHA1, TRIM25, BRCA1 | FNTA | ACVR1, TGFB1, PTP4A2, TGFBR1, HDAC6, VAV2, TGM2, INHBB, STAT2, SAFB2, RPL13A, DYRK1A, HK2, AMMECR1L, HEYL, NAP1L1, FNTB, DARS2, TOP1, BRCA1, BRAF, FGFR3, KDM6A, CAPN1, ARFGAP1, TSKS, RPL18, C10orf71, EPB41L5, FAM117B, ARNT2, XRCC3, ATAD5, BLM, MTOR, RPS19 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RANGAP1_FNTA |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RANGAP1_FNTA |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | RANGAP1 | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|